OptiCor, a cutting-edge Clinical Decision Support Software, leads the way in cardiovascular care by seamlessly incorporating the latest 2023 ACC/AHA Guideline for Atrial Fibrillation. With a validated risk prediction algorithm, OptiCor empowers healthcare professionals with individualized stroke risk assessments, navigating away from the conventional CHA2DS2-VASc scoring system. This paradigm shift aligns perfectly with the guideline's emphasis on personalized therapy decisions, resulting in a significant reduction in mortality, stroke, and bleeding compared to standard care. The user-friendly interface and EHR integration of the enhanced version position OptiCor as the exclusive solution for implementing the new guideline, reinforcing its commitment to shaping the future of cardiovascular care through evidence-based precision and innovation.

tenacio transforms cardiovascular care by using individual risk prediction and curated treatment recommendations which help health care providers to provide efficient care and optimal treatments for patients, resulting in better outcomes and lower cost.

Health systems use eCART to quickly and efficiently direct clinical resources toward their most critical patients and ensure timely and consistent care. Our sophisticated reporting and benchmarking further empower clinical leadership to understand and drive practice patterns. eCART draws upon readily available patient data from the EHR, rapidly quantifies disease severity, and predicts likelihood of critical illness onset, hours before it happens. Built upon more than a decade of ongoing scientific research, eCART was developed at the University of Chicago by Dr. Dana Edelson, MD, MS and Dr. Matthew Churpek, MD, PhD and is well chronicled in published literature. The analytic and workflow have been in use in clinical practice since 2016.

At AgileMD, we are building the most advanced real-time predictive analytics and clinical pathways platform for hospitals.

To date, AgileMD tools have been used on nearly 2.5 million patients by more than 80,000 providers in over 150 hospitals, including some of the nation's leading academic medical centers. AgileMD is backed by premier accelerators MATTER, YCombinator, and Rock Health, and our cutting-edge analytics are built on a decade of ongoing research at the University of Chicago. In 2021, AgileMD garnered nearly $3 million in combined federal research and development funding from the National Institutes of Health (NIH) and Health and Human Services (HHS) to further advance our platform.

OptiCor is the only Clinical Decision Support which incorporates the 2023 ACC/AHA AF Guideline because it provides precise treatment decisions based on individual stroke risk prediction.

Its focus is on proven outcome improvements and a superior user experience, making it easier and faster for HCPs to identify the optimal treatment for a patient. 

• Only CDS which supports the new 2023 ACC/AHA AF treatment paradigm
• Proven outcome benefits and cost savings
• Superior user experience
• FDA reviewed, proprietary and validated risk prediction algorithm

• 10+ years of published academic literature on value over other early warning scores
• Analytics derived and validated in robust patient datasets 
• Built by clinicians for clinicians, with full cross-team workflow to ensure risk scores are understood and acted upon

• 8+ years in clinical use
• High sensitiviy and specificity, meaning fewer false alarms and more efficient focus on the highest risk patients
• Integrated workflow to ensure that risk scores are not ignored and action is taken
• Robust reporting and benchmarking to drive quality improvement
• Deep EHR-integration